<?xml version="1.0" encoding="UTF-8"?><OAI-PMH
	xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2019-03-02T19:44:46Z</responseDate><request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:3375047" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request><GetRecord><record><header><identifier>oai:pubmedcentral.nih.gov:3375047</identifier><datestamp>2012-06-18</datestamp><setSpec>acssd</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.0/ https://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="research-article" xml:lang="EN">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">J Phys Chem B</journal-id>
      <journal-id journal-id-type="iso-abbrev">J Phys Chem B</journal-id>
      <journal-id journal-id-type="publisher-id">jp</journal-id>
      <journal-id journal-id-type="coden">jpcbfk</journal-id>
      <journal-title-group>
        <journal-title>The Journal of Physical Chemistry. B</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1520-6106</issn>
      <issn pub-type="epub">1520-5207</issn>
      <publisher>
        <publisher-name>American
Chemical Society</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC3375047</article-id>
      <article-id pub-id-type="pmcid">PMC3375047</article-id>
      <article-id pub-id-type="pmc-uid">3375047</article-id>
      <article-id pub-id-type="pmid">22329685</article-id>
      <article-id pub-id-type="doi">10.1021/jp212457w</article-id>
      <article-categories>
        <subj-group>
          <subject>Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Side Chain Independent
Recognition of Aminoacyl Adenylates by the Hint1 Transcription Suppressor</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" id="ath1">
          <name>
            <surname>Wang</surname>
            <given-names>Jing</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">â </xref>
        </contrib>
        <contrib contrib-type="author" id="ath2">
          <name>
            <surname>Fang</surname>
            <given-names>Pengfei</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">â </xref>
        </contrib>
        <contrib contrib-type="author" id="ath3">
          <name>
            <surname>Schimmel</surname>
            <given-names>Paul</given-names>
          </name>
          <xref rid="aff2" ref-type="aff">â¡</xref>
        </contrib>
        <contrib contrib-type="author" corresp="yes" id="ath4">
          <name>
            <surname>Guo</surname>
            <given-names>Min</given-names>
          </name>
          <xref rid="cor1" ref-type="other">*</xref>
          <xref rid="aff1" ref-type="aff">â </xref>
        </contrib>
        <aff id="aff1"><label>â </label>Department of Cancer Biology, <institution>The Scripps Research Institute, Scripps Florida</institution>, 130
Scripps Way, Jupiter, Florida 33458, United States</aff>
        <aff id="aff2"><label>â¡</label>The Skaggs Institute
for Chemical Biology and the Department of Molecular Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037, United States</aff>
      </contrib-group>
      <author-notes>
        <corresp id="cor1"><label>*</label>E-mail: <email>guomin@scripps.edu</email>.</corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>13</day>
        <month>02</month>
        <year>2012</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <day>14</day>
        <month>06</month>
        <year>2012</year>
      </pub-date>
      <volume>116</volume>
      <issue>23</issue>
      <issue-title>Harold A. Scheraga Festschrift</issue-title>
      <fpage>6798</fpage>
      <lpage>6805</lpage>
      <history>
        <date date-type="received">
          <day>24</day>
          <month>12</month>
          <year>2011</year>
        </date>
        <date date-type="rev-recd">
          <day>08</day>
          <month>02</month>
          <year>2012</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright Â© 2012 American Chemical Society</copyright-statement>
        <copyright-year>2012</copyright-year>
        <copyright-holder>American Chemical Society</copyright-holder>
        <license xlink:href="http://pubs.acs.org" license-type="open-access">
          <license-p>This is an open-access article distributed under the ACS AuthorChoice Terms &amp; Conditions. Any use of this article, must conform to the terms of that license which are available at <uri xlink:href="http://pubs.acs.org">http://pubs.acs.org</uri>.</license-p>
        </license>
      </permissions>
      <abstract>
        <p content-type="toc-graphic">
          <graphic xlink:href="jp-2011-12457w_0001" id="ab-d30e159"/>
        </p>
        <p>Human Hint1 suppresses specific gene transcription by
interacting with the transcription factor MITF in mast cells. Hint1
activity is connected to lysyl-tRNA synthetase (LysRS), a member of
the universal aminoacyl tRNA synthetase family that catalyzes specific
aminoacylation of their cognate tRNAs, through an aminoacyl adenylate
(aa-AMP) intermediate. During immune activation, LysRS produces a
side-product diadenosine tetraphosphate (Ap<sub>4</sub>A) from the
condensation of Lys-AMP with ATP. The pleiotropic signaling molecule
Ap<sub>4</sub>A then binds Hint1 to promote activation of MITF-target
gene transcription. Earlier work showed that Hint1 can also bind and
hydrolyze Lys-AMP, possibly to constrain Ap<sub>4</sub>A production.
Because Ap<sub>4</sub>A can result from condensation of other aa-AMP's
with ATP, the specificity of the Hint1 aa-AMPâhydrolysis activity
is of interest. Here we show that Hint1 has broad specificity for
adenylate hydrolysis, whose structural basis we revealed through high-resolution
structures of Hint1 in complex with three different aa-AMP analogues.
Hint1 recognizes only the common main chain of the aminoacyl moiety,
and has no contact with the aa side chain. The Î±-amino group
is anchored by a cation-pi interaction with Trp123 at the C-terminus
of Hint1. These results reveal the structural basis for the remarkable
adenylate surveillance activity of Hint1, to potentially control Ap<sub>4</sub>A levels in the cell.</p>
      </abstract>
      <funding-group>
        <funding-statement>
          <funding-source>National Institutes of Health, United States</funding-source>
        </funding-statement>
      </funding-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>document-id-old-9</meta-name>
          <meta-value>jp212457w</meta-value>
        </custom-meta>
        <custom-meta>
          <meta-name>document-id-new-14</meta-name>
          <meta-value>jp-2011-12457w</meta-value>
        </custom-meta>
        <custom-meta>
          <meta-name>ccc-price</meta-name>
          <meta-value/>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <!--with a head-->
    <sec id="sec1">
      <title>Introduction</title>
      <p>Hint1 is a member of a histidine triad
(HIT) protein family that is widespread in eukaryotes and bacteria.<sup><xref ref-type="bibr" rid="ref1">1</xref></sup> Hint1 acts as a haplo-insufficient tumor suppressor
whose deficiency in mice results in increased susceptibility to both
spontaneous and carcinogen-induced tumor formation.<sup><xref ref-type="bibr" rid="ref2">2</xref>,<xref ref-type="bibr" rid="ref3">3</xref></sup> Hint1
deficient cells are resistant to ionizing radiation-induced apoptosis.<sup><xref ref-type="bibr" rid="ref4">4</xref>,<xref ref-type="bibr" rid="ref5">5</xref></sup> Overexpression of Hint1 in nonsmall lung cancer cells led to cell
growth inhibition <italic>in vitro</italic> and to a reduction of
tumorigenicity <italic>in vivo</italic>.<sup><xref ref-type="bibr" rid="ref6">6</xref></sup> Additionally, Hint1 can bind to and has hydrolase activity toward
phosphoramidates and acyladenylates.<sup><xref ref-type="bibr" rid="ref7">7</xref>,<xref ref-type="bibr" rid="ref8">8</xref></sup> Hint1 also
associates with and suppresses the microphthalmia transcription factor
(MITF) and the upstream stimulatory factor 2 (USF2).<sup><xref ref-type="bibr" rid="ref9">9</xref>,<xref ref-type="bibr" rid="ref10">10</xref></sup> How these activities are associated with Hint1 suppressor function
remains unclear. Interestingly, regulation of Hint1 in mast cells
is at least in part through collaboration with a member of the aminoacyl
tRNA synthetase family.<sup><xref ref-type="bibr" rid="ref11">11</xref>â<xref ref-type="bibr" rid="ref13">13</xref></sup></p>
      <p>Aminoacyl-tRNA synthetases
(aaRS's) are essential enzymes that catalyze the attachment of amino
acids onto their cognate tRNAs in a two-step reaction.<sup><xref ref-type="bibr" rid="ref14">14</xref>,<xref ref-type="bibr" rid="ref15">15</xref></sup> The amino acid (aa) is first condensed with ATP to form a tightly
bound aminoacyl adenylate (aa-AMP), and inorganic pyrophosphate (PPi)
is released. The activated aa-AMP is then transferred from the adenylate
to the 3â² end of the tRNA to form aa-tRNA:<disp-formula id="eq1"><graphic xlink:href="jp-2011-12457w_m001" position="anchor"/><label>1</label></disp-formula><disp-formula id="eq2"><graphic xlink:href="jp-2011-12457w_m002" position="anchor"/><label>2</label></disp-formula>Some aaRS's also generate a signaling molecule
diadenosine tetraphosphate (AppppA or Ap<sub>4</sub>A) by catalyzing
a side reaction:<sup><xref ref-type="bibr" rid="ref16">16</xref></sup><disp-formula id="eq3"><graphic xlink:href="jp-2011-12457w_m003" position="anchor"/><label>3</label></disp-formula>Lysyl-tRNA synthetase (LysRS) is one of the
best-known aaRS's that produces Ap<sub>4</sub>A.<sup><xref ref-type="bibr" rid="ref17">17</xref>â<xref ref-type="bibr" rid="ref19">19</xref></sup> Higher eukaryotic
LysRS also joins with eight other aaRS's and three auxiliary proteins
(MSC p43, MSC p38, MSC p18, or named as AIMP1, AIMP2, AIMP3, respectively)
to form a high molecular mass multisynthetase complex (MSC).<sup><xref ref-type="bibr" rid="ref20">20</xref>â<xref ref-type="bibr" rid="ref23">23</xref></sup> Harboring almost half of the cellular tRNA synthetases, MSC is regarded
as a reservoir that controls the flow of tRNA synthetases between
translational and ex-translational functions.<sup><xref ref-type="bibr" rid="ref24">24</xref>,<xref ref-type="bibr" rid="ref25">25</xref></sup> For example, in immunologically activated mast cells, LysRS is released
from the MSC, produces Ap<sub>4</sub>A, and drives the expression
of microphthalmia associated transcription factor (MITF)-downstream
genes that regulate the immune response.<sup><xref ref-type="bibr" rid="ref11">11</xref>,<xref ref-type="bibr" rid="ref12">12</xref></sup></p>
      <p>Through
binding to MITF, Hint1 suppresses MITF activity in quiescent mast
cells.<sup><xref ref-type="bibr" rid="ref9">9</xref></sup> In stimulated mast cells, MITF
activation is accompanied by an increase of intracellular Ap<sub>4</sub>A, which promotes dissociation of the Hint1-MITF complex.<sup><xref ref-type="bibr" rid="ref9">9</xref>,<xref ref-type="bibr" rid="ref11">11</xref></sup>It has been demonstrated that Ap<sub>4</sub>A binds to Hint1 and
specifically dissociates the Hint1-MITF interaction.<sup><xref ref-type="bibr" rid="ref26">26</xref></sup> Additionally, directly adding Ap<sub>4</sub>A to the cell
medium, or siRNA knockdown of the Ap<sub>4</sub>A hydrolase, caused
dissociation of the Hint1-MITF complex and activated a subset of MITF-targeted
gene transcription.<sup><xref ref-type="bibr" rid="ref11">11</xref>,<xref ref-type="bibr" rid="ref13">13</xref>,<xref ref-type="bibr" rid="ref26">26</xref></sup> It was suggested that LysRS-produced Ap<sub>4</sub>A activates MITF
by binding and releasing Hint1.<sup><xref ref-type="bibr" rid="ref12">12</xref></sup></p>
      <p>Hint1 proteins contain a conserved HxHxHxx motif (x is hydrophobic)
that binds to and hydrolyzes purine-containing nucleotide derivatives
such as adenosine monophosphoramidate (AMP-NH<sub>2</sub>), AMP-<italic>N</italic>-Îµ-(<italic>N</italic>-Î±-acetyl lysine methyl
ester) (AMP-<italic>N</italic>-Îµ-lysine), and AMP-<italic>N</italic>-alanine methyl ester.<sup><xref ref-type="bibr" rid="ref27">27</xref></sup> On the other
hand, Hint1 also hydrolyzes Lys-AMP, the canonical intermediate product
of LysRS (eq <xref rid="eq1" ref-type="disp-formula">1</xref>).<sup><xref ref-type="bibr" rid="ref8">8</xref></sup> Therefore, Lys-AMP may play a role in the LysRS-Hint1-MITF pathway.<sup><xref ref-type="bibr" rid="ref28">28</xref></sup> For example, the destruction of Lys-AMP would
limit the amount of Ap<sub>4</sub>A that can be produced (eq <xref rid="eq3" ref-type="disp-formula">3</xref> above). In addition, because 5 mammalian aaRS's
(LysRS, ThrRS, SerRS, PheRS, GlyRS) and more than 10 aaRS's from other
species have been demonstrated to synthesize Ap<sub>4</sub>A,<sup><xref ref-type="bibr" rid="ref18">18</xref>,<xref ref-type="bibr" rid="ref29">29</xref>â<xref ref-type="bibr" rid="ref32">32</xref></sup> and because these synthetases also synthesize their respective aa-AMP
intermediate, we considered the possibility that the hydrolytic activity
of Hint1 may extend beyond Lys-AMP. Thus, if Ap<sub>4</sub>A was generated
by various synthetases, then the control of its level would necessitate
a broader specificity for aa-AMP hydrolysis, either by Hint1 or by
one or more other enzymes.</p>
      <p>We thus investigated the ability
of Hint1 to hydrolyze adenylates other than Lys-AMP. We showed that
Hint1 has broad specificity for aa-AMP hydrolysis, and does so through
a mechanism that exploits the histidine triad configuration of the
protein. To understand the molecular basis of this broad specificity,
we determined the crystal structures of Hint1 in complex with a stable
Lys-AMP analogue and, separately, with two other stable aminoacyl
adenylate analogues. The results reveal a new mechanism for binding
of aminoacyl adenylates (aa-AMP's), which is distinct from that seen
for the highly specific complexes of aa-AMP's with their cognate aminoacyl-tRNA
synthetases. Therefore, Hint1 binds and hydrolyzes a broad array of
aa-AMP's, suggesting that the levels of free adenylates and of Ap<sub>4</sub>A may be regulated by the Hint1 hydrolytic activity in the
cell.</p>
    </sec>
    <!--with a head-->
    <sec sec-type="results" id="sec2">
      <title>Results</title>
      <!--with a head-->
      <sec id="sec2.1">
        <title>Hint1 Reacts with Different aa-AMP's</title>
        <p>The intermediate
product of LysRS, Lys-AMP, contains a high-energy ester-phosphate
bond that can be cleaved when dissociated from LysRS and bound to
Hint1. The hydrolysis by Hint1 of LysRS-generated Lys-AMP can be monitored
by the formation of the Hint1-AMP intermediate.<sup><xref ref-type="bibr" rid="ref28">28</xref></sup> Because Hint1-AMP has a half-life of â¼0.3 s and
is less sensitive to base catalyzed hydrolysis,<sup><xref ref-type="bibr" rid="ref8">8</xref>,<xref ref-type="bibr" rid="ref28">28</xref></sup> it
represents a transiently modified form of Hint1 that could in principle
also have a specific function distinct from Hint1 itself. When <sc>l</sc>-lysine and Î±-<sup>32</sup>P-radiolabeled ATP are incubated
with an <italic>E. coli</italic> LysRS known as LysU, both human and <italic>E. coli</italic> Hint hydrolyze Lys-AMP and form the Hint1-AMP intermediate
state that can be detected by SDS-PAGE.<sup><xref ref-type="bibr" rid="ref28">28</xref>,<xref ref-type="bibr" rid="ref33">33</xref>,<xref ref-type="bibr" rid="ref34">34</xref></sup> This method of detection of Hint1-AMP is a definitive
way to measure the ability of Hint1 to react with various aminoacyl-tRNA
synthetase-produced aa-AMP's.</p>
        <p>For this purpose, several amino
acids (<sc>l</sc>-Ala, <sc>l</sc>-Asp, <sc>l</sc>-Met, <sc>l</sc>-His,
and <sc>l</sc>-Lys) with distinct side chains were incubated with
their cognate tRNA synthetase and with human Hint1. Formation of Hint1-AMP
was detected for <sc>l</sc>-Lys/LysRS, indicating the Lys-AMP generated
by LysRS reacts with Hint1 wild type (WT), and to a lesser extent
with an active site mutant Hint1_H114A (see below) (Figure <xref rid="fig1" ref-type="fig">1</xref>). In addition, formation of Hint1-AMP was also
detected for each other amino acid/tRNA synthetase pair, with each
yielding approximately the same amount of product within the same
time period. Importantly, no Hint1-AMP was formed when Hint1 was incubated
with the four noncognate tRNA synthetases and <sc>l</sc>-Lys. This
observation is consistent with the expectation that Hint1 is labeled
by capture of the aa-AMP generated from each tRNA synthetase (Figure <xref rid="fig1" ref-type="fig">1</xref>). Thus, Hint1 binds and reacts with different aa-AMP's
produced by other tRNA synthetases.</p>
        <fig id="fig1" position="float">
          <label>Figure 1</label>
          <caption>
            <p>aa-AMP hydrolysis by Hint1 is general.
Hint1 was incubated with alpha-<sup>32</sup>P-ATP, <sc>l</sc>-lysine,
and separately with five different tRNA synthetases, with/without
the cognate amino acids. The reaction was quenched at 1 min and analyzed
by SDS-PAGE and autoradiography. Although lysine is present in each
reaction mixture, Hint1-AMP only forms when LysRS is present, or when
there is another tRNA synthetase with its cognate amino acid. An active
site mutant Hint1_H114A, which was characterized in this work, was
also used to coincubate with LysRS and <sc>l</sc>-Lys.</p>
          </caption>
          <graphic xlink:href="jp-2011-12457w_0003" id="gr1" position="float"/>
        </fig>
      </sec>
      <!--with a head-->
      <sec id="sec2.2">
        <title>Complex Structures of Hint1 with Lys-AMS</title>
        <p>Although the
hydrolysis of Lys-AMP by Hint1 was previously established,<sup><xref ref-type="bibr" rid="ref28">28</xref>,<xref ref-type="bibr" rid="ref35">35</xref></sup> no detailed understanding of the interaction of Hint1 with adenylates
has been reported. In order to obtain a structure of a complex, Lys-AMS
([<italic>N</italic>-(<sc>l</sc>-lysyl)sulfamoyl]adenosine), the nonhydrolyzable
analogue of Lys-AMP, was cocrystallized at a concentration of 5 mM
with human Hint1 (Figure <xref rid="fig2" ref-type="fig">2</xref>A). The Hint1/Lys-AMS
complex structure was solved at a resolution of 1.52 Ã. Each
asymmetric unit in the crystal contained two Hint1 molecules. As previously
observed in other human Hint1 structures, the two Hint1âs form
an extended Î²-sheet-like dimer that creates two purine nucleotide-binding
sites.<sup><xref ref-type="bibr" rid="ref36">36</xref>,<xref ref-type="bibr" rid="ref37">37</xref></sup> Interestingly, only one subunit of the Hint1
dimer bound Lys-AMS. The binding site in the second subunit of the
homodimer was blocked by crystal packing interactions.</p>
        <fig id="fig2" position="float">
          <label>Figure 2</label>
          <caption>
            <p>Complex structure of
human Hint1 with Lys-AMS, Ala-AMS, and Trp-AMS. (A) Dimeric structure
of Hint1 in complex with Lys-AMS. One subunit of the Hint1 dimer contains
the ligand. (BâD) Electron density maps of the bound aa-AMS
analogues. The refined 2Fo-Fc density maps are shown at 1.0 Ï.
Chemical structures of the analogues are shown on the right, with
electron densities missing from the side chains highlighted by shading
on the chemical structures.</p>
          </caption>
          <graphic xlink:href="jp-2011-12457w_0004" id="gr2" position="float"/>
        </fig>
        <p>The electron density of the ligand could be clearly
identified, including the adenosine moiety, the sulfate-substituted
group, and the N-substituted covalent bond between the lysyl moietyâs
backbone atoms C, CÎ±, and N and the sulfate. However, no density
for the lysyl side chain could be seen beyond CÎ² in the electron
density map (shown at contour level of 1 Ï of 2Fo-Fc map) (Figure <xref rid="fig2" ref-type="fig">2</xref>B). This observation suggests that the side chain
of Lys-AMS adopts a free conformation, such that its electron density
is averaged out in the crystal.</p>
      </sec>
      <!--with a head-->
      <sec id="sec2.3">
        <title>Side Chain Independent Recognition of Hint1 with aa-AMP Analogues</title>
        <p>The Hint1/Lys-AMS structure showed that Hint1 only recognized the
main chain of the lysyl group. The Î±-amino group of the lysyl
backbone is placed on top of Trp123 of Hint1. Because the amino group
is likely to be protonated under the conditions of crystallization
(pH 7.5), at the close distance of 3.5 Ã, it forms a cation-pi
interaction with the aromatic side chain of Trp123.<sup><xref ref-type="bibr" rid="ref38">38</xref></sup> With lateral support from the side chains of Gln47, Arg95,
Val97, and Leu116, and from Pro125 from the back, the indole side
chain of Trp123 forms a rigid wall for the lysyl-binding pocket (rmsd
of 0.3 Ã between the structure of the apoprotein and of the Lys-AMS
complex) (Figure <xref rid="fig3" ref-type="fig">3</xref>A).<sup><xref ref-type="bibr" rid="ref37">37</xref></sup> Consistent with the important role of Trp123 for recognizing the
lysyl backbone, mutation of Trp123 to Ala showed both a lag in the
formation of Hint1-AMP and a decrease in the total amount of Hint1-AMP
that was generated (Figure <xref rid="fig3" ref-type="fig">3</xref>C). In addition,
the carbonyl group of the lysyl moiety formed one hydrogen bond with
the side chain of N99, together with two internal hydrogen bonds with
the Î±-amino group of the lysyl and sulfate groups. The N-substituted
oxygen of Lys-AMS also formed hydrogen bonds with Ser107, Gly105,
and Asn99. Thus, Lys-AMS is bound at a defined position in Hint1.</p>
        <fig id="fig3" position="float">
          <label>Figure 3</label>
          <caption>
            <p>Hydrolysis
of Lys-AMP by Hint1. (A) Detailed interaction of Lys-AMS with human
Hint1. The Î±-amino group of the lysyl group in Lys-AMS forms
a cation-Ï interaction with the aromatic ring of Trp123. (B)
Structural superimposition of Hint1/Lys-AMS with the transition state
complex of Hint1/adenosine-5â²-ditungstate (Ade-W2O6, PDB <ext-link ext-link-type="pdb" xlink:href="6FIT">6FIT</ext-link>). The sulfate group
of Lys-AMS is located close to the Î± tungstate group of Ade-W2O6.
A yellow dashed line indicates the covalent bond formed between the
Î± tungsten (brown) and NÎµ of the H112 side chain. The
overlapped adenosine moieties of these two ligands are not shown.
(C) Formation of the covalent Hint1-AMP intermediate shows the important
role of H114 and W123 for hydrolysis of Lys-AMP. The reaction conditions
are as described in the legend to Figure <xref rid="fig1" ref-type="fig">1</xref>.
(D) Sequence alignment of vertebrate HINT proteins. Critical residues
involved in the binding and hydrolysis of aa-AMP's are boxed in red,
and are conserved in Hint1âs and its Hint2 paralogs (which
function in mitochondria). Different residues are found in Hint3's,
whose function is less characterized.<sup><xref ref-type="bibr" rid="ref52">52</xref></sup> (E) Catalytic mechanism proposed for the hydrolysis of aa-AMP's
by human Hint1.</p>
          </caption>
          <graphic xlink:href="jp-2011-12457w_0005" id="gr3" position="float"/>
        </fig>
        <p>Because of the confined binding pocket shaped by
Trp123, the side chain of Lys-AMS is oriented toward the solvent (Figure <xref rid="fig3" ref-type="fig">3</xref>A). Having no interaction with Hint1, the side chain
of the lysyl moiety is free to rotate and therefore is completely
disordered in the crystal. For this reason, we speculated that Hint1
would not be specific to Lys-AMP and would likely bind different aa-AMP's
from other tRNA synthetases.</p>
        <p>To test this hypothesis, we crystallized
Hint1 in complex with two other aminoacyl-AMP analogues, i.e., Ala-AMS
and Trp-AMS. Consistent with expectations, the electron density of
the tryptophanyl side chain was not seen in the Trp-AMS complex with
Hint1 (Figure <xref rid="fig2" ref-type="fig">2</xref>D). Only the adenylate moiety,
the main chain, and the CÎ² of the side chain of Trp-AMS had
clear electron densities. These densities resembled the electron densities
of Ala-AMS within its Hint1 complex (Figure <xref rid="fig2" ref-type="fig">2</xref>C). Thus, the three crystal structures of the Hint1/aa-AMS complexes
suggest that the side chain of aa-AMP is not recognized by Hint1.</p>
      </sec>
      <!--with a head-->
      <sec id="sec2.4">
        <title>Mechanism of Lys-AMP Hydrolysis by Hint1</title>
        <p>Several structures
of mammalian Hint1 in apo-form, in complex with AMP (one of the products
of adenylate hydrolysis), GMP, the substrate analogue AMPCP, and the
transition state analogue adenosine-5â²-ditungstate have been
reported.<sup><xref ref-type="bibr" rid="ref36">36</xref>,<xref ref-type="bibr" rid="ref37">37</xref>,<xref ref-type="bibr" rid="ref39">39</xref>,<xref ref-type="bibr" rid="ref40">40</xref></sup> Structural comparisons showed that the AMS moiety
of Lys-AMS (with sulfur substitution of the phosphate) occupied the
same position as AMP in the Hint1/AMP complex. The sulfate group of
Lys-AMS binds to two (His112, His114) of the three characteristic
histidines in Hint1 (Figure <xref rid="fig3" ref-type="fig">3</xref>A). Previous results
showed that adenosine and sodium tungstate formed a covalently linked
complex (adenosine-5â²-ditungstate) with Hint1.<sup><xref ref-type="bibr" rid="ref36">36</xref></sup> The tungstate ion reacted with the imidazole side chain
of His112 of Hint1 through a pentacovalent complex with the NÎµ
of His112, to thus mimic the transient Hint1-AMP-P complex. Superimpositions
of the different Hint1 complexes showed that the sulfur atom of Lys-AMS
is at the position equivalent to the Î±-phosphorus atom of AMPCP
in the substrate analogue complex (0.4 Ã distance). This sulfur
is also close to the tungsten atom in the adenosine-5â²-ditungstate
complex (distance of 0.4 Ã, Figure <xref rid="fig3" ref-type="fig">3</xref>B).
In addition, the sulfate of Lys-AMS interacts with His114 and Asn99,
both of which are conserved in Hint1 proteins (Figure <xref rid="fig3" ref-type="fig">3</xref>B,D). Thus, Lys-AMS binds to Hint1 in a productive manner
for hydrolysis, and the Hint1/Lys-AMS structure appears to recapitulate
the bound conformation for native Lys-AMP.</p>
        <p>Hydrolysis of Lys-AMP
is likely through the same mechanism that Hint1 hydrolyzes other substrates,
such as ADP or AMP-NH<sub>2</sub>.<sup><xref ref-type="bibr" rid="ref27">27</xref>,<xref ref-type="bibr" rid="ref28">28</xref>,<xref ref-type="bibr" rid="ref36">36</xref></sup> Binding of Lys-AMP initiates an in-line attack on
the Î± phosphate by histidine (His112) as the nucleophile (Figure <xref rid="fig3" ref-type="fig">3</xref>E). A pentacovalent transition state inverts the
Î±-phosphate position (as also seen in the amino acid activation
step by tRNA synthetases).<sup><xref ref-type="bibr" rid="ref36">36</xref>,<xref ref-type="bibr" rid="ref41">41</xref></sup> Next, AMP is covalently
linked to His112 of Hint1 to form a nucleotidyl phosphoprotein (Hint1-AMP)
intermediate, and lysine is subsequently released. Finally, AMP is
hydrolyzed from Hint1 by a water molecule probably facilitated by
Ser107.<sup><xref ref-type="bibr" rid="ref40">40</xref></sup> The other conserved His residue
(His114) forms an electron transfer chain between His51 and the sulfate
group of Lys-AMS (Figure <xref rid="fig3" ref-type="fig">3</xref>A,B,E), and may thereby
help to stabilize the transition state. Mutating this His residue
(His114) to Ala dramatically decreased the amount of Hint1-AMP that
was formed, thus supporting the idea that His114 is also a critical
residue for the hydrolysis of Lys-AMP (Figure <xref rid="fig3" ref-type="fig">3</xref>C). Importantly, binding and hydrolysis of Lys-AMP involves only
the recognition of AMP and the lysyl backbone. Therefore, this hydrolysis
mechanism would be applicable to aa-AMP's generated from other aaRS's
(Figure <xref rid="fig3" ref-type="fig">3</xref>E).</p>
      </sec>
    </sec>
    <!--with a head-->
    <sec sec-type="discussion" id="sec3">
      <title>Discussion</title>
      <!--with a head-->
      <sec id="sec3.1">
        <title>Trp123 Has an Important Role for Substrate Recognition by Hint1</title>
        <p>Hint1 is a member of the HIT superfamily that is divided into many
branches including the Hint branch, the fragile histidine triad (Fhit)
branch, and the galactose-1-phosphate uridyltransferase (GalT) branch.<sup><xref ref-type="bibr" rid="ref42">42</xref></sup> Each branch has a different substrate specificity.<sup><xref ref-type="bibr" rid="ref27">27</xref></sup> In contrast to Fhit, which hydrolyzes diadenosine-polyphosphates
(such as Ap<sub>3</sub>A), Hint1 shows weak activity toward ADP (<italic>k</italic><sub>cat</sub> of 10<sup>â3</sup> s<sup>â1</sup> and <italic>K</italic><sub>m</sub> of 800 Î¼M) and no activity
toward other nucleotides with multiple phosphates such as ATP and
Ap<sub><italic>n</italic></sub>A (<italic>n</italic> = 3â5).<sup><xref ref-type="bibr" rid="ref36">36</xref></sup> On the other hand, Hint1 preferentially binds
and hydrolyzes adenosine derivatives with a single phosphate, including
phosphoramidates (e.g., AMP-NH<sub>2</sub>, AMP-N-Ala, AMP-N-Îµ-Lys,)
and acyl adenylates (e.g., Lys-AMP), and has turnover rates <italic>k</italic><sub>cat</sub> as high as â¼2 s<sup>â1</sup> and <italic>K</italic><sub>m</sub> values as low as â¼0.1
Î¼M.<sup><xref ref-type="bibr" rid="ref34">34</xref>,<xref ref-type="bibr" rid="ref39">39</xref></sup> Except for the characteristic AMP-binding
pocket in Hint1, the structures of the Hint1/aa-AMS complexes showed
that the main chain of the aminoacyl group was placed into a groove
formed by Trp123. The Î±-amino group of the aminoacyl moiety
stacked on top of the imidazole side chain of Trp123, by forming a
cation-pi interaction (Figure <xref rid="fig2" ref-type="fig">2</xref>). Similar interactions
are also found in the amino acid binding pocket of AlaRS and SerRS,
where a strictly conserved Trp residue supports the backbone of the
bound amino acid.<sup><xref ref-type="bibr" rid="ref41">41</xref>,<xref ref-type="bibr" rid="ref43">43</xref></sup> (Presumably, a phosphate group
in ADP or Ap<sub><italic>n</italic></sub>A at the position of the
Î±-amino group will form a less favorable interaction with Trp123,
and this circumstance would give a lower affinity for Hint1.) However,
for AlaRS and SerRS, and unlike Hint1, there are also specific interactions
and pockets for the alanyl and seryl side chains.</p>
        <p>Interestingly,
Trp123 is located at the C-terminus of human Hint1 (126 residues)
and is one of the 15 residues that are sexually dimorphic in avian <italic>HINT</italic>-related genes, which were suggested to be responsible
for feminization.<sup><xref ref-type="bibr" rid="ref44">44</xref></sup> Recent biochemical
studies established an important role for the C-terminus of Hint1.
Swapping of the C-terminal seven residues of human Hint1 to <italic>E. coli</italic> Hint changed the substrate specificity.<sup><xref ref-type="bibr" rid="ref33">33</xref></sup> In addition, deletion of three C-terminal residues
abolished the ability of <italic>E. coli</italic> Hint to hydrolyze
Lys-AMP. However, the deletion only had a modest effect on acyl-adenylate
substrates that do not contain the aminoacyl backbone.<sup><xref ref-type="bibr" rid="ref35">35</xref></sup> In the structure of rabbit Hint1 in complex with an AMP-N-Îµ-Lys
analogue, Trp123 interacts with the alkyl portion of the lysyl leaving
group.<sup><xref ref-type="bibr" rid="ref39">39</xref></sup> Substitution of Trp123 to Gln,
which is present in female-specific avian <italic>HINT</italic>-related
genes, reduced <italic>k</italic><sub>cat</sub>/<italic>K</italic><sub>m</sub> for AMP-N-Îµ-lysine hydrolysis by 17-fold.<sup><xref ref-type="bibr" rid="ref44">44</xref></sup> Consistent with these results, our work showed
that the Trp123Ala mutation at the C-terminus of Hint1 caused a dramatic
loss of activity in forming the human Hint1-AMP intermediate, and
thereby emphasized the importance of Trp123 in the hydrolysis of Lys-AMP.</p>
      </sec>
      <!--with a head-->
      <sec id="sec3.2">
        <title>General Specificity of Hint1 for aa-AMP's</title>
        <p>In the structures
of Hint1/aa-AMS complexes, the aminoacyl backbone of Lys-AMS (or Ala-AMS,
Trp-AMS) was oriented toward the outside of Hint1 (Figure <xref rid="fig4" ref-type="fig">4</xref>). The interaction mode between Hint1 and Lys-AMP
contrasts with that of the LysRS/Lys-AMP complex, as seen in structures
of LysRS in complex with Lys-AMP, or with <sc>l</sc>-lysine and ATP.<sup><xref ref-type="bibr" rid="ref45">45</xref>,<xref ref-type="bibr" rid="ref46">46</xref></sup> In order to recognize lysine and attach it to the cognate tRNA<sup>Lys</sup>, LysRS forms a deep pocket that specifically accommodates
only lysine. Two strictly conserved glutamic acid side chains (Glu240
and Glu428 in <italic>E. coli</italic> LysU and Glu301 and Glu501
in human LysRS) are located at the end of the pocket, where they recognize
the Îµ-amino of the lysine side chain (Figure <xref rid="fig4" ref-type="fig">4</xref>B). Also different from the cation-pi interaction in Hint1,
the Î±-amino group of the lysyl moiety is anchored by hydrogen
bonds with two Gluâs in LysRS (Glu240 and Glu278 in LysU and
Glu301 and Glu339 in human LysRS). The carboxyl group of the lysyl
moiety interacts with the characteristic Arg262 in LysU and is positioned
to react with the Î±-phosphate group of ATP. Comparison of the
Hint1/Lys-AMS and LysRS/Lys-AMS cocrystal structures shows that the
Lys-AMS pockets in these two proteins are in opposite directions.
While in LysRS the lysyl moiety is facing inside and AMP/ATP faces
outside, AMP is inside and the lysyl group is facing outside in Hint1
(Figure <xref rid="fig4" ref-type="fig">4</xref>). Similarly, the ligand electron
densities in the structures of Hint1 with Ala-AMS and Trp-AMS also
show that no side chain of any aminoacyl group is involved in an interaction
with Hint1 (Figure <xref rid="fig2" ref-type="fig">2</xref>).</p>
        <fig id="fig4" position="float">
          <label>Figure 4</label>
          <caption>
            <p>Recognition of Lys-AMP
by Hint1 vs LysRS. The Lys-AMS binding pocket of human Hint1 in comparison
with the pocket of LysRS (PDB <ext-link ext-link-type="pdb" xlink:href="1E1T">1E1T</ext-link>) shows side chain independent recognition of Lys-AMP
by Hint1. Residues responsible for recognition of the lysyl-AMS in
Hint1 and LysRS are depicted. The potential direction of the Lys side
chain in the Hint1/Lys-AMS structure is shown as a dashed line.</p>
          </caption>
          <graphic xlink:href="jp-2011-12457w_0006" id="gr4" position="float"/>
        </fig>
        <p>An important link between Hint1 and aaRS's was
found during the immune activation of mast cells, where LysRS contributed
to an â¼3-fold increase of intracellular Ap<sub>4</sub>A.<sup><xref ref-type="bibr" rid="ref12">12</xref></sup> Earlier work showed that Ap<sub>4</sub>A binding
to Hint1 could dissociate the Hint1-MITF complex. This effect appears
to be specific because other Ap<sub><italic>n</italic></sub>A (<italic>n</italic> = 3, 5) did not cause dissociation.<sup><xref ref-type="bibr" rid="ref11">11</xref></sup> Lys-AMP, with a size between Ap<sub>3</sub>A and AMP, is
less likely to dissociate the Hint1-MITF interaction. In addition,
because the hydrolysis product AMP could not dissociate the Hint1-MITF
interaction, the hydrolysis of Lys-AMP by Hint1 may also alleviate
the effect of Lys-AMP.<sup><xref ref-type="bibr" rid="ref11">11</xref></sup> On the other hand,
the adenylation of Hint1 by AlaRS, MetRS, HisRS, and AspRS shows that
Hint1 hydrolyzes various aa-AMP's (Figure <xref rid="fig1" ref-type="fig">1</xref>). Binding and hydrolysis of aa-AMP's by Hint1 is through a common
mechanism, as evidenced by the formation of the Hint1-AMP intermediate
with all tested aaRS's. This broad activity of human Hint1 to bind
and hydrolyze aa-AMP's is caused by the unique binding pocket involving
Trp123, which is conserved in Hint1 proteins from <italic>C. elegans</italic> to human.<sup><xref ref-type="bibr" rid="ref1">1</xref></sup> With more than half of the
aaRS members including LysRS, AlaRS, and MetRS known to synthesize
Ap<sub>4</sub>A <italic>in vitro</italic> and/or in cells,<sup><xref ref-type="bibr" rid="ref18">18</xref>,<xref ref-type="bibr" rid="ref30">30</xref>,<xref ref-type="bibr" rid="ref47">47</xref></sup> Hint1 may have a general ability
to constrain the formation of Ap<sub>4</sub>A by the aaRS family.
In addition, we cannot rule out the possibility that the transient
Hint1-AMP complex, and complexes of Hint1 with other aminoacyl adenylates,
also play a role in regulating the functions of Hint1.</p>
      </sec>
    </sec>
    <!--with a head-->
    <sec sec-type="methods" id="sec4">
      <title>Methods</title>
      <!--with a head-->
      <sec id="sec4.1">
        <title>Protein Preparation</title>
        <p>The gene encoding human Hint1 was
synthesized by codon optimization. Human Hint1 was constructed with
a N-terminal 6xHis-tag with a TEV protease cleavage site in a pHisTEV
vector. Human Hint1 was expressed in the bacterial strain BL21(DE3)
at 16 Â°C for 20 h and purified to homogeneity with a Ni-HiTrap
affinity column (GE Healthcare, Piscataway, NJ). The 6xHis-TEV tag
was cleaved by TEV protease, and the nontagged Hint1 was further purified
by a HiTrap SP Sepharose column (GE Healthcare, Piscataway, NJ). It
was concentrated to 50 mg/mL in a final buffer (10 mM TrisâHCl,
pH 8.0, 50 mM NaCl) for crystallization. Full-length AlaRS, AspRS,
HisRS, and MetRS were cloned from the <italic>E. coli</italic> genome
K12 and were inserted into pET vectors (Novagen, Darmstadt, Germany)
with the 6xHis-tag. These proteins were expressed in the bacterial
strain BL21(DE3) (NEB, Ipswich, MA) at 37 Â°C for 6 h and purified
to homogeneity with the Ni-HiTrap affinity column.</p>
      </sec>
      <!--with a head-->
      <sec id="sec4.2">
        <title>Crystallization, Data Collection, and Structure Refinement</title>
        <p>Crystallization was done by the sitting drop method. Protein solution
(nontagged recombinant human Hint1 (see above)) was preincubated with
5 mM Lys-AMS, Ala-AMS, or Trp-AMS for 10 min at 22 Â°C. A drop
was prepared by mixing 0.5 Î¼L of protein solution with 0.5 Î¼L
of precipitant solution, containing 25â28% PEG3350, 100 mM
HEPES pH 7.5, and was equilibrated against 90 Î¼L of precipitant
solution. Crystals were collected after incubation at 18 Â°C for
3â7 days and were flash-frozen in liquid nitrogen for data
collection.</p>
        <p>Three data sets were obtained from Beamline 11-1
at the Stanford Synchrotron Radiation Laboratory (Menlo Park, CA).
The crystals belong to space group <italic>C</italic>2 with two molecules
of Hint1 per asymmetric unit. The structures were solved by molecular
replacement using the Hint1 apo structure (PDB <ext-link ext-link-type="pdb" xlink:href="6RHN">6RHN</ext-link>) with the program
Molrep.<sup><xref ref-type="bibr" rid="ref48">48</xref></sup> Iterative model building and
refinement were performed by using Coot and Phenix.<sup><xref ref-type="bibr" rid="ref49">49</xref>,<xref ref-type="bibr" rid="ref50">50</xref></sup> Data collection and refinement statistics are given in Table <xref rid="tbl1" ref-type="other">1</xref>.</p>
        <table-wrap id="tbl1" position="float">
          <label>Table 1</label>
          <caption>
            <title>Data Collection and Refinement Statistics</title>
          </caption>
          <table frame="hsides" rules="groups" border="0">
            <colgroup>
              <col align="left"/>
              <col align="left"/>
              <col align="left"/>
              <col align="left"/>
            </colgroup>
            <thead>
              <tr>
                <th style="border:none;" align="center">Â </th>
                <th style="border:none;" align="center">Hint1/Ala-AMS</th>
                <th style="border:none;" align="center">Hint1/Lys-AMS</th>
                <th style="border:none;" align="center">Hint1/Trp-AMS</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td colspan="4" style="border:none;" align="center">Data Collection</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">space group</td>
                <td style="border:none;" align="left"><italic>C</italic>2</td>
                <td style="border:none;" align="left"><italic>C</italic>2</td>
                <td style="border:none;" align="left"><italic>C</italic>2</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">cell dimensions</td>
                <td style="border:none;" align="left">Â </td>
                <td style="border:none;" align="left">Â </td>
                <td style="border:none;" align="left">Â </td>
              </tr>
              <tr>
                <td style="padding-left: 2em;" align="left"><italic>a</italic>, <italic>b</italic>, <italic>c</italic> (Ã)</td>
                <td style="border:none;" align="left">78.31, 46.37,
64.11</td>
                <td style="border:none;" align="left">79.00, 46.41, 64.23</td>
                <td style="border:none;" align="left">79.00, 46.43,
63.88</td>
              </tr>
              <tr>
                <td style="padding-left: 2em;" align="left">Î±, Î², Î³ (deg)</td>
                <td style="border:none;" align="left">90.00, 95.02, 90.00</td>
                <td style="border:none;" align="left">90.00, 95.46, 90.00</td>
                <td style="border:none;" align="left">90.00, 95.24, 90.00</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">resolution (Ã)</td>
                <td style="border:none;" align="left">50.00â1.52(1.57â1.52)<xref rid="t1fn1" ref-type="table-fn">a</xref></td>
                <td style="border:none;" align="left">25.00â1.52(1.57â1.52)</td>
                <td style="border:none;" align="left">25.00â1.67(1.73â1.67)</td>
              </tr>
              <tr>
                <td style="border:none;" align="left"><italic>R</italic><sub>sym</sub> or <italic>R</italic><sub>merge</sub> (%)</td>
                <td style="border:none;" align="left">3.9Â (11.5)</td>
                <td style="border:none;" align="left">4.8Â (29.9)</td>
                <td style="border:none;" align="left">5.3Â (48.9)</td>
              </tr>
              <tr>
                <td style="border:none;" align="left"><italic>I</italic>/s<italic>I</italic></td>
                <td style="border:none;" align="left">42.5Â (16.8)</td>
                <td style="border:none;" align="left">38.96Â (6.4)</td>
                <td style="border:none;" align="left">35.2Â (3.4)</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">completeness (%)</td>
                <td style="border:none;" align="left">98.4Â (97.1)</td>
                <td style="border:none;" align="left">99.3Â (98.2)</td>
                <td style="border:none;" align="left">98.4Â (96.7)</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">redundancy</td>
                <td style="border:none;" align="left">7.5Â (6.7)</td>
                <td style="border:none;" align="left">7.5Â (6.5)</td>
                <td style="border:none;" align="left">7.5Â (7.3)</td>
              </tr>
              <tr>
                <td colspan="4" style="border:none;" align="center">Refinement</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">resolution (Ã)</td>
                <td style="border:none;" align="left">50.00â1.52(1.56â1.52)</td>
                <td style="border:none;" align="left">25.00â1.52(1.56â1.52)</td>
                <td style="border:none;" align="left">25.00â1.67(1.74â1.67)</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">no. reflections</td>
                <td style="border:none;" align="left">34772</td>
                <td style="border:none;" align="left">34771</td>
                <td style="border:none;" align="left">25244</td>
              </tr>
              <tr>
                <td style="border:none;" align="left"><italic>R</italic><sub>work</sub>/<italic>R</italic><sub>free</sub> (%)</td>
                <td style="border:none;" align="left">14.1/16.4</td>
                <td style="border:none;" align="left">14.2/16.2</td>
                <td style="border:none;" align="left">14.4/17.3</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">no. atoms</td>
                <td style="border:none;" align="left">Â </td>
                <td style="border:none;" align="left">Â </td>
                <td style="border:none;" align="left">Â </td>
              </tr>
              <tr>
                <td style="padding-left: 2em;" align="left">protein</td>
                <td style="border:none;" align="left">1826</td>
                <td style="border:none;" align="left">1805</td>
                <td style="border:none;" align="left">1788</td>
              </tr>
              <tr>
                <td style="padding-left: 2em;" align="left">ligand</td>
                <td style="border:none;" align="left">28</td>
                <td style="border:none;" align="left">28</td>
                <td style="border:none;" align="left">28</td>
              </tr>
              <tr>
                <td style="padding-left: 2em;" align="left">solvent</td>
                <td style="border:none;" align="left">306</td>
                <td style="border:none;" align="left">300</td>
                <td style="border:none;" align="left">302</td>
              </tr>
              <tr>
                <td style="border:none;" align="left"><italic>B</italic>-factors (Ã<sup>2</sup>)</td>
                <td style="border:none;" align="left">Â </td>
                <td style="border:none;" align="left">Â </td>
                <td style="border:none;" align="left">Â </td>
              </tr>
              <tr>
                <td style="padding-left: 2em;" align="left">protein</td>
                <td style="border:none;" align="left">12.11</td>
                <td style="border:none;" align="left">13.98</td>
                <td style="border:none;" align="left">13.95</td>
              </tr>
              <tr>
                <td style="padding-left: 2em;" align="left">ligand</td>
                <td style="border:none;" align="left">16.07</td>
                <td style="border:none;" align="left">19.25</td>
                <td style="border:none;" align="left">26.33</td>
              </tr>
              <tr>
                <td style="padding-left: 2em;" align="left">solvent</td>
                <td style="border:none;" align="left">28.20</td>
                <td style="border:none;" align="left">31.48</td>
                <td style="border:none;" align="left">31.42</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">rms deviations</td>
                <td style="border:none;" align="left">Â </td>
                <td style="border:none;" align="left">Â </td>
                <td style="border:none;" align="left">Â </td>
              </tr>
              <tr>
                <td style="padding-left: 2em;" align="left">bond lengths
(Ã)</td>
                <td style="border:none;" align="left">0.007</td>
                <td style="border:none;" align="left">0.008</td>
                <td style="border:none;" align="left">0.009</td>
              </tr>
              <tr>
                <td style="padding-left: 2em;" align="left">bond angles
(deg)</td>
                <td style="border:none;" align="left">1.242</td>
                <td style="border:none;" align="left">1.189</td>
                <td style="border:none;" align="left">1.250</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">Ramachandran plot</td>
                <td style="border:none;" align="left">Â </td>
                <td style="border:none;" align="left">Â </td>
                <td style="border:none;" align="left">Â </td>
              </tr>
              <tr>
                <td style="padding-left: 2em;" align="left">most favored (%)</td>
                <td style="border:none;" align="left">98.8%</td>
                <td style="border:none;" align="left">98.7%</td>
                <td style="border:none;" align="left">98.7%</td>
              </tr>
              <tr>
                <td style="padding-left: 2em;" align="left">additional allowed (%)</td>
                <td style="border:none;" align="left">1.2%</td>
                <td style="border:none;" align="left">1.3%</td>
                <td style="border:none;" align="left">1.3%</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn id="t1fn1">
              <label>a</label>
              <p>Values in parentheses are for the
highest-resolution shell.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
      </sec>
      <!--with a head-->
      <sec id="sec4.3">
        <title>Enzymatic Assays</title>
        <p>All assays for Hint1-AMP formation
were carried out in a standard buffer (50 mM Hepes-Na, pH 7.5, 20
mM KCl, 10 mM MgCl<sub>2</sub>, 2 mM DTT, 0.16 Î¼M Î±-<sup>32</sup>P-ATP, 3 Î¼g/mL inorganic pyrophosphatase, and 100 Î¼M
amino acid) at 22 Â°C. Wild-type or mutant Hint1 (0.5 Î¼M)
was coincubated with human LysRS,<sup><xref ref-type="bibr" rid="ref51">51</xref></sup> or <italic>E. coli</italic> AlaRS, AspRS, HisRS, or MetRS (0.5 Î¼M). The
reaction was quenched at each time point by adding equal amounts of
2Ã SDS-PAGE sample buffer and boiled for 5 min at 95 Â°C.
Equal amounts of each sample were load onto a 4â20% SDS-PAGE
gel, which ran to the point that most of the free ATP was eluted from
the gel. Radioactive bands of Hint1 and AMP were detected by phosphoimaging
(Molecular Imager FX, Biorad, Hercules, CA) over a time period of
12â30 h.</p>
      </sec>
    </sec>
  </body>
  <back>
    <notes id="NOTES-d626e1196-autogenerated" notes-type="conflict-of-interest">
      <p>The authors declare no competing
financial interest.</p>
    </notes>
    <ack>
      <title>Acknowledgments</title>
      <p>Crystal data collection was carried out at the Stanford Synchrotron
Radiation Laboratory, a national user facility operated by Stanford
University on behalf of the U.S. Department of Energy, Office of Basic
Energy Sciences. This work was supported in part by GM15539 from the
NIH, by a fellowship from the National Foundation for Cancer Research,
by a Kimmel Scholar Award for Cancer Research, and by funding from
The State of Florida to Scripps Florida.</p>
    </ack>
    <ref-list>
      <title>References</title>
      <ref id="ref1">
        <mixed-citation publication-type="journal" id="cit1"><name><surname>Brenner</surname><given-names>C.</given-names></name>; <name><surname>Bieganowski</surname><given-names>P.</given-names></name>; <name><surname>Pace</surname><given-names>H. C.</given-names></name>; <name><surname>Huebner</surname><given-names>K.</given-names></name>
<source>J. Cell. Physiol.</source>
<year>1999</year>, <volume>181</volume>, <fpage>179</fpage>â<lpage>187</lpage>.<pub-id pub-id-type="pmid">10497298</pub-id></mixed-citation>
      </ref>
      <ref id="ref2">
        <mixed-citation publication-type="journal" id="cit2"><name><surname>Su</surname><given-names>T.</given-names></name>; <name><surname>Suzui</surname><given-names>M.</given-names></name>; <name><surname>Wang</surname><given-names>L.</given-names></name>; <name><surname>Lin</surname><given-names>C. S.</given-names></name>; <name><surname>Xing</surname><given-names>W. Q.</given-names></name>; <name><surname>Weinstein</surname><given-names>I. B.</given-names></name>
<source>Proc. Natl. Acad.
Sci. U.S.A.</source>
<year>2003</year>, <volume>100</volume>, <fpage>7824</fpage>â<lpage>7829</lpage>.<pub-id pub-id-type="pmid">12810953</pub-id></mixed-citation>
      </ref>
      <ref id="ref3">
        <mixed-citation publication-type="journal" id="cit3"><name><surname>Li</surname><given-names>H.</given-names></name>; <name><surname>Zhang</surname><given-names>Y.</given-names></name>; <name><surname>Su</surname><given-names>T.</given-names></name>; <name><surname>Santella</surname><given-names>R. M.</given-names></name>; <name><surname>Weinstein</surname><given-names>I. B.</given-names></name>
<source>Oncogene</source>
<year>2006</year>, <volume>25</volume>, <fpage>713</fpage>â<lpage>721</lpage>.<pub-id pub-id-type="pmid">16186798</pub-id></mixed-citation>
      </ref>
      <ref id="ref4">
        <mixed-citation publication-type="journal" id="cit4"><name><surname>Li</surname><given-names>H.</given-names></name>; <name><surname>Balajee</surname><given-names>A. S.</given-names></name>; <name><surname>Su</surname><given-names>T.</given-names></name>; <name><surname>Cen</surname><given-names>B.</given-names></name>; <name><surname>Hei</surname><given-names>T. K.</given-names></name>; <name><surname>Weinstein</surname><given-names>I. B.</given-names></name>
<source>J. Cell Biol.</source>
<year>2008</year>, <volume>183</volume>, <fpage>253</fpage>â<lpage>265</lpage>.<pub-id pub-id-type="pmid">18852295</pub-id></mixed-citation>
      </ref>
      <ref id="ref5">
        <mixed-citation publication-type="journal" id="cit5"><name><surname>Weiske</surname><given-names>J.</given-names></name>; <name><surname>Huber</surname><given-names>O.</given-names></name>
<source>J.
Biol. Chem.</source>
<year>2006</year>, <volume>281</volume>, <fpage>27356</fpage>â<lpage>27366</lpage>.<pub-id pub-id-type="pmid">16835243</pub-id></mixed-citation>
      </ref>
      <ref id="ref6">
        <mixed-citation publication-type="journal" id="cit6"><name><surname>Yuan</surname><given-names>B. Z.</given-names></name>; <name><surname>Jefferson</surname><given-names>A. M.</given-names></name>; <name><surname>Popescu</surname><given-names>N. C.</given-names></name>; <name><surname>Reynolds</surname><given-names>S. H.</given-names></name>
<source>Neoplasia</source>
<year>2004</year>, <volume>6</volume>, <fpage>412</fpage>â<lpage>419</lpage>.<pub-id pub-id-type="pmid">15256063</pub-id></mixed-citation>
      </ref>
      <ref id="ref7">
        <mixed-citation publication-type="journal" id="cit7"><name><surname>Bieganowski</surname><given-names>P.</given-names></name>; <name><surname>Garrison</surname><given-names>P. N.</given-names></name>; <name><surname>Hodawadekar</surname><given-names>S. C.</given-names></name>; <name><surname>Faye</surname><given-names>G.</given-names></name>; <name><surname>Barnes</surname><given-names>L. D.</given-names></name>; <name><surname>Brenner</surname><given-names>C.</given-names></name>
<source>J. Biol. Chem.</source>
<year>2002</year>, <volume>277</volume>, <fpage>10852</fpage>â<lpage>10860</lpage>.<pub-id pub-id-type="pmid">11805111</pub-id></mixed-citation>
      </ref>
      <ref id="ref8">
        <mixed-citation publication-type="journal" id="cit8"><name><surname>Chou</surname><given-names>T. F.</given-names></name>; <name><surname>Baraniak</surname><given-names>J.</given-names></name>; <name><surname>Kaczmarek</surname><given-names>R.</given-names></name>; <name><surname>Zhou</surname><given-names>X.</given-names></name>; <name><surname>Cheng</surname><given-names>J.</given-names></name>; <name><surname>Ghosh</surname><given-names>B.</given-names></name>; <name><surname>Wagner</surname><given-names>C. R.</given-names></name>
<source>Mol. Pharm.</source>
<year>2007</year>, <volume>4</volume>, <fpage>208</fpage>â<lpage>217</lpage>.<pub-id pub-id-type="pmid">17217311</pub-id></mixed-citation>
      </ref>
      <ref id="ref9">
        <mixed-citation publication-type="journal" id="cit9"><name><surname>Razin</surname><given-names>E.</given-names></name>; <name><surname>Zhang</surname><given-names>Z. C.</given-names></name>; <name><surname>Nechushtan</surname><given-names>H.</given-names></name>; <name><surname>Frenkel</surname><given-names>S.</given-names></name>; <name><surname>Lee</surname><given-names>Y. N.</given-names></name>; <name><surname>Arudchandran</surname><given-names>R.</given-names></name>; <name><surname>Rivera</surname><given-names>J.</given-names></name>
<source>J. Biol. Chem.</source>
<year>1999</year>, <volume>274</volume>, <fpage>34272</fpage>â<lpage>34276</lpage>.<pub-id pub-id-type="pmid">10567402</pub-id></mixed-citation>
      </ref>
      <ref id="ref10">
        <mixed-citation publication-type="journal" id="cit10"><name><surname>Lee</surname><given-names>Y. N.</given-names></name>; <name><surname>Razin</surname><given-names>E.</given-names></name>
<source>Mol. Cell. Biol.</source>
<year>2005</year>, <volume>25</volume>, <fpage>8904</fpage>â<lpage>8912</lpage>.<pub-id pub-id-type="pmid">16199869</pub-id></mixed-citation>
      </ref>
      <ref id="ref11">
        <mixed-citation publication-type="journal" id="cit11"><name><surname>Lee</surname><given-names>Y. N.</given-names></name>; <name><surname>Nechushtan</surname><given-names>H.</given-names></name>; <name><surname>Figov</surname><given-names>N.</given-names></name>; <name><surname>Razin</surname><given-names>E.</given-names></name>
<source>Immunity</source>
<year>2004</year>, <volume>20</volume>, <fpage>145</fpage>â<lpage>151</lpage>.<pub-id pub-id-type="pmid">14975237</pub-id></mixed-citation>
      </ref>
      <ref id="ref12">
        <mixed-citation publication-type="journal" id="cit12"><name><surname>Yannay-Cohen</surname><given-names>N.</given-names></name>; <name><surname>Carmi-Levy</surname><given-names>I.</given-names></name>; <name><surname>Kay</surname><given-names>G.</given-names></name>; <name><surname>Yang</surname><given-names>C. M.</given-names></name>; <name><surname>Han</surname><given-names>J. M.</given-names></name>; <name><surname>Kemeny</surname><given-names>D. M.</given-names></name>; <name><surname>Kim</surname><given-names>S.</given-names></name>; <name><surname>Nechushtan</surname><given-names>H.</given-names></name>; <name><surname>Razin</surname><given-names>E.</given-names></name>
<source>Mol.
Cell</source>
<year>2009</year>, <volume>34</volume>, <fpage>603</fpage>â<lpage>611</lpage>.<pub-id pub-id-type="pmid">19524539</pub-id></mixed-citation>
      </ref>
      <ref id="ref13">
        <mixed-citation publication-type="journal" id="cit13"><name><surname>Carmi-Levy</surname><given-names>I.</given-names></name>; <name><surname>Motzik</surname><given-names>A.</given-names></name>; <name><surname>Ofir-Birin</surname><given-names>Y.</given-names></name>; <name><surname>Yagil</surname><given-names>Z.</given-names></name>; <name><surname>Yang</surname><given-names>C. M.</given-names></name>; <name><surname>Kemeny</surname><given-names>D. M.</given-names></name>; <name><surname>Han</surname><given-names>J. M.</given-names></name>; <name><surname>Kim</surname><given-names>S.</given-names></name>; <name><surname>Kay</surname><given-names>G.</given-names></name>; <name><surname>Nechushtan</surname><given-names>H.</given-names></name>; <name><surname>Suzuki</surname><given-names>R.</given-names></name>; <name><surname>Rivera</surname><given-names>J.</given-names></name>; <name><surname>Razin</surname><given-names>E.</given-names></name>
<source>Mol. Cell. Biol.</source>
<year>2011</year>, <volume>31</volume>, <fpage>2111</fpage>â<lpage>2121</lpage>.<pub-id pub-id-type="pmid">21402779</pub-id></mixed-citation>
      </ref>
      <ref id="ref14">
        <mixed-citation publication-type="journal" id="cit14"><name><surname>Carter</surname><given-names>C. W.</given-names><suffix>Jr.</suffix></name>
<source>Annu. Rev. Biochem.</source>
<year>1993</year>, <volume>62</volume>, <fpage>715</fpage>â<lpage>748</lpage>.<pub-id pub-id-type="pmid">8352600</pub-id></mixed-citation>
      </ref>
      <ref id="ref15">
        <mixed-citation publication-type="journal" id="cit15"><name><surname>Ibba</surname><given-names>M.</given-names></name>; <name><surname>Soll</surname><given-names>D.</given-names></name>
<source>Annu. Rev. Biochem.</source>
<year>2000</year>, <volume>69</volume>, <fpage>617</fpage>â<lpage>650</lpage>.<pub-id pub-id-type="pmid">10966471</pub-id></mixed-citation>
      </ref>
      <ref id="ref16">
        <mixed-citation publication-type="journal" id="cit16"><name><surname>Goerlich</surname><given-names>O.</given-names></name>; <name><surname>Foeckler</surname><given-names>R.</given-names></name>; <name><surname>Holler</surname><given-names>E.</given-names></name>
<source>Eur. J. Biochem.</source>
<year>1982</year>, <volume>126</volume>, <fpage>135</fpage>â<lpage>142</lpage>.<pub-id pub-id-type="pmid">7128581</pub-id></mixed-citation>
      </ref>
      <ref id="ref17">
        <mixed-citation publication-type="journal" id="cit17"><name><surname>Wahab</surname><given-names>S. Z.</given-names></name>; <name><surname>Yang</surname><given-names>D. C.</given-names></name>
<source>J. Biol. Chem.</source>
<year>1985</year>, <volume>260</volume>, <fpage>5286</fpage>â<lpage>5289</lpage>.<pub-id pub-id-type="pmid">3988754</pub-id></mixed-citation>
      </ref>
      <ref id="ref18">
        <mixed-citation publication-type="journal" id="cit18"><name><surname>Brevet</surname><given-names>A.</given-names></name>; <name><surname>Chen</surname><given-names>J.</given-names></name>; <name><surname>Leveque</surname><given-names>F.</given-names></name>; <name><surname>Plateau</surname><given-names>P.</given-names></name>; <name><surname>Blanquet</surname><given-names>S.</given-names></name>
<source>Proc. Natl. Acad. Sci. U.S.A.</source>
<year>1989</year>, <volume>86</volume>, <fpage>8275</fpage>â<lpage>8279</lpage>.<pub-id pub-id-type="pmid">2554306</pub-id></mixed-citation>
      </ref>
      <ref id="ref19">
        <mixed-citation publication-type="journal" id="cit19"><name><surname>Wright</surname><given-names>M.</given-names></name>; <name><surname>Boonyalai</surname><given-names>N.</given-names></name>; <name><surname>Tanner</surname><given-names>J. A.</given-names></name>; <name><surname>Hindley</surname><given-names>A. D.</given-names></name>; <name><surname>Miller</surname><given-names>A. D.</given-names></name>
<source>FEBS J.</source>
<year>2006</year>, <volume>273</volume>, <fpage>3534</fpage>â<lpage>3544</lpage>.<pub-id pub-id-type="pmid">16884494</pub-id></mixed-citation>
      </ref>
      <ref id="ref20">
        <mixed-citation publication-type="journal" id="cit20"><name><surname>Kellermann</surname><given-names>O.</given-names></name>; <name><surname>Tonetti</surname><given-names>H.</given-names></name>; <name><surname>Brevet</surname><given-names>A.</given-names></name>; <name><surname>Mirande</surname><given-names>M.</given-names></name>; <name><surname>Pailliez</surname><given-names>J. P.</given-names></name>; <name><surname>Waller</surname><given-names>J. P.</given-names></name>
<source>J. Biol. Chem.</source>
<year>1982</year>, <volume>257</volume>, <fpage>11041</fpage>â<lpage>11048</lpage>.<pub-id pub-id-type="pmid">7107644</pub-id></mixed-citation>
      </ref>
      <ref id="ref21">
        <mixed-citation publication-type="journal" id="cit21"><name><surname>Kerjan</surname><given-names>P.</given-names></name>; <name><surname>Cerini</surname><given-names>C.</given-names></name>; <name><surname>Semeriva</surname><given-names>M.</given-names></name>; <name><surname>Mirande</surname><given-names>M.</given-names></name>
<source>Biochim. Biophys. Acta</source>
<year>1994</year>, <volume>1199</volume>, <fpage>293</fpage>â<lpage>297</lpage>.<pub-id pub-id-type="pmid">8161568</pub-id></mixed-citation>
      </ref>
      <ref id="ref22">
        <mixed-citation publication-type="journal" id="cit22"><name><surname>Rho</surname><given-names>S. B.</given-names></name>; <name><surname>Kim</surname><given-names>M. J.</given-names></name>; <name><surname>Lee</surname><given-names>J. S.</given-names></name>; <name><surname>Seol</surname><given-names>W.</given-names></name>; <name><surname>Motegi</surname><given-names>H.</given-names></name>; <name><surname>Kim</surname><given-names>S.</given-names></name>; <name><surname>Shiba</surname><given-names>K.</given-names></name>
<source>Proc.
Natl. Acad. Sci. U.S.A.</source>
<year>1999</year>, <volume>96</volume>, <fpage>4488</fpage>â<lpage>4493</lpage>.<pub-id pub-id-type="pmid">10200289</pub-id></mixed-citation>
      </ref>
      <ref id="ref23">
        <mixed-citation publication-type="journal" id="cit23"><name><surname>Kaminska</surname><given-names>M.</given-names></name>; <name><surname>Havrylenko</surname><given-names>S.</given-names></name>; <name><surname>Decottignies</surname><given-names>P.</given-names></name>; <name><surname>Gillet</surname><given-names>S.</given-names></name>; <name><surname>Le Marechal</surname><given-names>P.</given-names></name>; <name><surname>Negrutskii</surname><given-names>B.</given-names></name>; <name><surname>Mirande</surname><given-names>M.</given-names></name>
<source>J. Biol. Chem.</source>
<year>2009</year>, <volume>284</volume>, <fpage>6053</fpage>â<lpage>6060</lpage>.<pub-id pub-id-type="pmid">19131329</pub-id></mixed-citation>
      </ref>
      <ref id="ref24">
        <mixed-citation publication-type="journal" id="cit24"><name><surname>Park</surname><given-names>S. G.</given-names></name>; <name><surname>Ewalt</surname><given-names>K. L.</given-names></name>; <name><surname>Kim</surname><given-names>S.</given-names></name>
<source>Trends Biochem. Sci.</source>
<year>2005</year>, <volume>30</volume>, <fpage>569</fpage>â<lpage>574</lpage>.<pub-id pub-id-type="pmid">16125937</pub-id></mixed-citation>
      </ref>
      <ref id="ref25">
        <mixed-citation publication-type="journal" id="cit25"><name><surname>Ray</surname><given-names>P. S.</given-names></name>; <name><surname>Arif</surname><given-names>A.</given-names></name>; <name><surname>Fox</surname><given-names>P. L.</given-names></name>
<source>Trends Biochem.
Sci.</source>
<year>2007</year>, <volume>32</volume>, <fpage>158</fpage>â<lpage>164</lpage>.<pub-id pub-id-type="pmid">17321138</pub-id></mixed-citation>
      </ref>
      <ref id="ref26">
        <mixed-citation publication-type="journal" id="cit26"><name><surname>Carmi-Levy</surname><given-names>I.</given-names></name>; <name><surname>Yannay-Cohen</surname><given-names>N.</given-names></name>; <name><surname>Kay</surname><given-names>G.</given-names></name>; <name><surname>Razin</surname><given-names>E.</given-names></name>; <name><surname>Nechushtan</surname><given-names>H.</given-names></name>
<source>Mol. Cell. Biol.</source>
<year>2008</year>, <volume>28</volume>, <fpage>5777</fpage>â<lpage>5784</lpage>.<pub-id pub-id-type="pmid">18644867</pub-id></mixed-citation>
      </ref>
      <ref id="ref27">
        <mixed-citation publication-type="journal" id="cit27"><name><surname>Brenner</surname><given-names>C.</given-names></name>
<source>Biochemistry</source>
<year>2002</year>, <volume>41</volume>, <fpage>9003</fpage>â<lpage>9014</lpage>.<pub-id pub-id-type="pmid">12119013</pub-id></mixed-citation>
      </ref>
      <ref id="ref28">
        <mixed-citation publication-type="journal" id="cit28"><name><surname>Chou</surname><given-names>T. F.</given-names></name>; <name><surname>Wagner</surname><given-names>C. R.</given-names></name>
<source>J. Biol. Chem.</source>
<year>2007</year>, <volume>282</volume>, <fpage>4719</fpage>â<lpage>4727</lpage>.<pub-id pub-id-type="pmid">17158446</pub-id></mixed-citation>
      </ref>
      <ref id="ref29">
        <mixed-citation publication-type="journal" id="cit29"><name><surname>Blanquet</surname><given-names>S.</given-names></name>; <name><surname>Plateau</surname><given-names>P.</given-names></name>; <name><surname>Brevet</surname><given-names>A.</given-names></name>
<source>Mol. Cell. Biochem.</source>
<year>1983</year>, <volume>52</volume>, <fpage>3</fpage>â<lpage>11</lpage>.<pub-id pub-id-type="pmid">6346051</pub-id></mixed-citation>
      </ref>
      <ref id="ref30">
        <mixed-citation publication-type="journal" id="cit30"><name><surname>Brevet</surname><given-names>A.</given-names></name>; <name><surname>Plateau</surname><given-names>P.</given-names></name>; <name><surname>Cirakoglu</surname><given-names>B.</given-names></name>; <name><surname>Pailliez</surname><given-names>J. P.</given-names></name>; <name><surname>Blanquet</surname><given-names>S.</given-names></name>
<source>J. Biol. Chem.</source>
<year>1982</year>, <volume>257</volume>, <fpage>14613</fpage>â<lpage>14615</lpage>.<pub-id pub-id-type="pmid">7174656</pub-id></mixed-citation>
      </ref>
      <ref id="ref31">
        <mixed-citation publication-type="journal" id="cit31"><name><surname>Guo</surname><given-names>R. T.</given-names></name>; <name><surname>Chong</surname><given-names>Y. E.</given-names></name>; <name><surname>Guo</surname><given-names>M.</given-names></name>; <name><surname>Yang</surname><given-names>X. L.</given-names></name>
<source>J. Biol. Chem.</source>
<year>2009</year>, <volume>284</volume>, <fpage>28968</fpage>â<lpage>28976</lpage>.<pub-id pub-id-type="pmid">19710017</pub-id></mixed-citation>
      </ref>
      <ref id="ref32">
        <mixed-citation publication-type="book" id="cit32"><person-group person-group-type="allauthors"><name><surname>Plateau</surname><given-names>P.</given-names></name>; <name><surname>Blanquet</surname><given-names>S.</given-names></name></person-group><article-title>Synthesis of NpnNâ²
(n = 3 or 4) in vitro and in in vivo</article-title>. In <source>Ap4A
and Other Dinucleoside Polyphosphates</source>; <person-group person-group-type="editor"><name><surname>McLennan</surname><given-names>A. G.</given-names></name></person-group>, Ed.; <publisher-name>CRC
Press, Inc.</publisher-name>: <publisher-loc>Boca Raton, FL</publisher-loc>, <year>1992</year>; pp <fpage>63</fpage>â<lpage>80</lpage>.</mixed-citation>
      </ref>
      <ref id="ref33">
        <mixed-citation publication-type="journal" id="cit33"><name><surname>Chou</surname><given-names>T. F.</given-names></name>; <name><surname>Sham</surname><given-names>Y. Y.</given-names></name>; <name><surname>Wagner</surname><given-names>C. R.</given-names></name>
<source>Biochemistry</source>
<year>2007</year>, <volume>46</volume>, <fpage>13074</fpage>â<lpage>13079</lpage>.<pub-id pub-id-type="pmid">17939685</pub-id></mixed-citation>
      </ref>
      <ref id="ref34">
        <mixed-citation publication-type="journal" id="cit34"><name><surname>Chou</surname><given-names>T. F.</given-names></name>; <name><surname>Tikh</surname><given-names>I. B.</given-names></name>; <name><surname>Horta</surname><given-names>B. A.</given-names></name>; <name><surname>Ghosh</surname><given-names>B.</given-names></name>; <name><surname>De Alencastro</surname><given-names>R. B.</given-names></name>; <name><surname>Wagner</surname><given-names>C. R.</given-names></name>
<source>J. Biol. Chem.</source>
<year>2007</year>, <volume>282</volume>, <fpage>15137</fpage>â<lpage>15147</lpage>.<pub-id pub-id-type="pmid">17337452</pub-id></mixed-citation>
      </ref>
      <ref id="ref35">
        <mixed-citation publication-type="journal" id="cit35"><name><surname>Bardaweel</surname><given-names>S.</given-names></name>; <name><surname>Pace</surname><given-names>J.</given-names></name>; <name><surname>Chou</surname><given-names>T. F.</given-names></name>; <name><surname>Cody</surname><given-names>V.</given-names></name>; <name><surname>Wagner</surname><given-names>C. R.</given-names></name>
<source>J. Mol. Biol.</source>
<year>2010</year>, <volume>404</volume>, <fpage>627</fpage>â<lpage>638</lpage>.<pub-id pub-id-type="pmid">20934431</pub-id></mixed-citation>
      </ref>
      <ref id="ref36">
        <mixed-citation publication-type="journal" id="cit36"><name><surname>Lima</surname><given-names>C. D.</given-names></name>; <name><surname>Klein</surname><given-names>M. G.</given-names></name>; <name><surname>Hendrickson</surname><given-names>W. A.</given-names></name>
<source>Science</source>
<year>1997</year>, <volume>278</volume>, <fpage>286</fpage>â<lpage>290</lpage>.<pub-id pub-id-type="pmid">9323207</pub-id></mixed-citation>
      </ref>
      <ref id="ref37">
        <mixed-citation publication-type="journal" id="cit37"><name><surname>Brenner</surname><given-names>C.</given-names></name>; <name><surname>Garrison</surname><given-names>P.</given-names></name>; <name><surname>Gilmour</surname><given-names>J.</given-names></name>; <name><surname>Peisach</surname><given-names>D.</given-names></name>; <name><surname>Ringe</surname><given-names>D.</given-names></name>; <name><surname>Petsko</surname><given-names>G. A.</given-names></name>; <name><surname>Lowenstein</surname><given-names>J. M.</given-names></name>
<source>Nat. Struct. Biol.</source>
<year>1997</year>, <volume>4</volume>, <fpage>231</fpage>â<lpage>238</lpage>.<pub-id pub-id-type="pmid">9164465</pub-id></mixed-citation>
      </ref>
      <ref id="ref38">
        <mixed-citation publication-type="journal" id="cit38"><name><surname>Gallivan</surname><given-names>J. P.</given-names></name>; <name><surname>Dougherty</surname><given-names>D. A.</given-names></name>
<source>Proc. Natl. Acad.
Sci. U.S.A.</source>
<year>1999</year>, <volume>96</volume>, <fpage>9459</fpage>â<lpage>9464</lpage>.<pub-id pub-id-type="pmid">10449714</pub-id></mixed-citation>
      </ref>
      <ref id="ref39">
        <mixed-citation publication-type="journal" id="cit39"><name><surname>Krakowiak</surname><given-names>A.</given-names></name>; <name><surname>Pace</surname><given-names>H. C.</given-names></name>; <name><surname>Blackburn</surname><given-names>G. M.</given-names></name>; <name><surname>Adams</surname><given-names>M.</given-names></name>; <name><surname>Mekhalfia</surname><given-names>A.</given-names></name>; <name><surname>Kaczmarek</surname><given-names>R.</given-names></name>; <name><surname>Baraniak</surname><given-names>J.</given-names></name>; <name><surname>Stec</surname><given-names>W. J.</given-names></name>; <name><surname>Brenner</surname><given-names>C.</given-names></name>
<source>J. Biol. Chem.</source>
<year>2004</year>, <volume>279</volume>, <fpage>18711</fpage>â<lpage>18716</lpage>.<pub-id pub-id-type="pmid">14982931</pub-id></mixed-citation>
      </ref>
      <ref id="ref40">
        <mixed-citation publication-type="journal" id="cit40"><name><surname>Ozga</surname><given-names>M.</given-names></name>; <name><surname>Dolot</surname><given-names>R.</given-names></name>; <name><surname>Janicka</surname><given-names>M.</given-names></name>; <name><surname>Kaczmarek</surname><given-names>R.</given-names></name>; <name><surname>Krakowiak</surname><given-names>A.</given-names></name>
<source>J. Biol. Chem.</source>
<year>2010</year>, <volume>285</volume>, <fpage>40809</fpage>â<lpage>40818</lpage>.<pub-id pub-id-type="pmid">20940308</pub-id></mixed-citation>
      </ref>
      <ref id="ref41">
        <mixed-citation publication-type="journal" id="cit41"><name><surname>Guo</surname><given-names>M.</given-names></name>; <name><surname>Chong</surname><given-names>Y. E.</given-names></name>; <name><surname>Shapiro</surname><given-names>R.</given-names></name>; <name><surname>Beebe</surname><given-names>K.</given-names></name>; <name><surname>Yang</surname><given-names>X. L.</given-names></name>; <name><surname>Schimmel</surname><given-names>P.</given-names></name>
<source>Nature</source>
<year>2009</year>, <volume>462</volume>, <fpage>808</fpage>â<lpage>812</lpage>.<pub-id pub-id-type="pmid">20010690</pub-id></mixed-citation>
      </ref>
      <ref id="ref42">
        <mixed-citation publication-type="journal" id="cit42"><name><surname>Huebner</surname><given-names>K.</given-names></name>; <name><surname>Saldivar</surname><given-names>J. C.</given-names></name>; <name><surname>Sun</surname><given-names>J.</given-names></name>; <name><surname>Shibata</surname><given-names>H.</given-names></name>; <name><surname>Druck</surname><given-names>T.</given-names></name>
<source>Adv.
Enzyme Regul.</source>
<year>2011</year>, <volume>51</volume>, <fpage>208</fpage>â<lpage>217</lpage>.<pub-id pub-id-type="pmid">21035495</pub-id></mixed-citation>
      </ref>
      <ref id="ref43">
        <mixed-citation publication-type="journal" id="cit43"><name><surname>Bilokapic</surname><given-names>S.</given-names></name>; <name><surname>Maier</surname><given-names>T.</given-names></name>; <name><surname>Ahel</surname><given-names>D.</given-names></name>; <name><surname>Gruic-Sovulj</surname><given-names>I.</given-names></name>; <name><surname>Soll</surname><given-names>D.</given-names></name>; <name><surname>Weygand-Durasevic</surname><given-names>I.</given-names></name>; <name><surname>Ban</surname><given-names>N.</given-names></name>
<source>EMBO
J.</source>
<year>2006</year>, <volume>25</volume>, <fpage>2498</fpage>â<lpage>2509</lpage>.<pub-id pub-id-type="pmid">16675947</pub-id></mixed-citation>
      </ref>
      <ref id="ref44">
        <mixed-citation publication-type="journal" id="cit44"><name><surname>Parks</surname><given-names>K. P.</given-names></name>; <name><surname>Seidle</surname><given-names>H.</given-names></name>; <name><surname>Wright</surname><given-names>N.</given-names></name>; <name><surname>Sperry</surname><given-names>J. B.</given-names></name>; <name><surname>Bieganowski</surname><given-names>P.</given-names></name>; <name><surname>Howitz</surname><given-names>K.</given-names></name>; <name><surname>Wright</surname><given-names>D. L.</given-names></name>; <name><surname>Brenner</surname><given-names>C.</given-names></name>
<source>Physiol. Genomics</source>
<year>2004</year>, <volume>20</volume>, <fpage>12</fpage>â<lpage>14</lpage>.<pub-id pub-id-type="pmid">15507519</pub-id></mixed-citation>
      </ref>
      <ref id="ref45">
        <mixed-citation publication-type="journal" id="cit45"><name><surname>Desogus</surname><given-names>G.</given-names></name>; <name><surname>Todone</surname><given-names>F.</given-names></name>; <name><surname>Brick</surname><given-names>P.</given-names></name>; <name><surname>Onesti</surname><given-names>S.</given-names></name>
<source>Biochemistry</source>
<year>2000</year>, <volume>39</volume>, <fpage>8418</fpage>â<lpage>8425</lpage>.<pub-id pub-id-type="pmid">10913247</pub-id></mixed-citation>
      </ref>
      <ref id="ref46">
        <mixed-citation publication-type="journal" id="cit46"><name><surname>Guo</surname><given-names>M.</given-names></name>; <name><surname>Ignatov</surname><given-names>M.</given-names></name>; <name><surname>Musier-Forsyth</surname><given-names>K.</given-names></name>; <name><surname>Schimmel</surname><given-names>P.</given-names></name>; <name><surname>Yang</surname><given-names>X. L.</given-names></name>
<source>Proc. Natl. Acad. Sci. U.S.A.</source>
<year>2008</year>, <volume>105</volume>, <fpage>2331</fpage>â<lpage>2336</lpage>.<pub-id pub-id-type="pmid">18272479</pub-id></mixed-citation>
      </ref>
      <ref id="ref47">
        <mixed-citation publication-type="book" id="cit47"><person-group person-group-type="allauthors"><name><surname>Blanquet</surname><given-names>S.</given-names></name>; <name><surname>Plateau</surname><given-names>P.</given-names></name>; <name><surname>Onesti</surname><given-names>S.</given-names></name></person-group><article-title>Class II Lysyl-tRNA Synthetases</article-title>. In <source>The Aminoacyl-tRNA
Synthetases</source>; <person-group person-group-type="editor"><name><surname>Ibba</surname><given-names>M.</given-names></name>, <name><surname>Francklyn</surname><given-names>C.</given-names></name>, <name><surname>Cusack</surname><given-names>S.</given-names></name></person-group>,
Eds.; <publisher-name>Eurekah</publisher-name>: <publisher-loc>Georgetown, TX</publisher-loc>, <year>2005</year>; pp <fpage>227</fpage>â<lpage>240</lpage>.</mixed-citation>
      </ref>
      <ref id="ref48">
        <mixed-citation publication-type="journal" id="cit48">Winn, M. D.; et al. <source>Acta Crystallogr., Sect. D: Biol. Crystallogr.</source><year>2011</year>, <volume>67</volume>, <fpage>235</fpage>â<lpage>242</lpage>.<pub-id pub-id-type="pmid">21460441</pub-id></mixed-citation>
      </ref>
      <ref id="ref49">
        <mixed-citation publication-type="journal" id="cit49"><name><surname>Emsley</surname><given-names>P.</given-names></name>; <name><surname>Cowtan</surname><given-names>K.</given-names></name>
<source>Acta Crystallogr., Sect. D: Biol. Crystallogr.</source>
<year>2004</year>, <volume>60</volume>, <fpage>2126</fpage>â<lpage>2132</lpage>.<pub-id pub-id-type="pmid">15572765</pub-id></mixed-citation>
      </ref>
      <ref id="ref50">
        <mixed-citation publication-type="journal" id="cit50"><name><surname>Adams</surname><given-names>P. D.</given-names></name>; <name><surname>Mustyakimov</surname><given-names>M.</given-names></name>; <name><surname>Afonine</surname><given-names>P. V.</given-names></name>; <name><surname>Langan</surname><given-names>P.</given-names></name>
<source>Acta Crystallogr., Sect. D: Biol. Crystallogr.</source>
<year>2009</year>, <volume>65</volume>, <fpage>567</fpage>â<lpage>573</lpage>.<pub-id pub-id-type="pmid">19465771</pub-id></mixed-citation>
      </ref>
      <ref id="ref51">
        <mixed-citation publication-type="journal" id="cit51"><name><surname>Fang</surname><given-names>P.</given-names></name>; <name><surname>Zhang</surname><given-names>H. M.</given-names></name>; <name><surname>Shapiro</surname><given-names>R.</given-names></name>; <name><surname>Marshall</surname><given-names>A. G.</given-names></name>; <name><surname>Schimmel</surname><given-names>P.</given-names></name>; <name><surname>Yang</surname><given-names>X. L.</given-names></name>; <name><surname>Guo</surname><given-names>M.</given-names></name>
<source>Proc. Natl. Acad.
Sci. U.S.A.</source>
<year>2011</year>, <volume>108</volume>, <fpage>8239</fpage>â<lpage>8244</lpage>.<pub-id pub-id-type="pmid">21536907</pub-id></mixed-citation>
      </ref>
      <ref id="ref52">
        <mixed-citation publication-type="journal" id="cit52"><name><surname>Martin</surname><given-names>J.</given-names></name>; <name><surname>St-Pierre</surname><given-names>M. V.</given-names></name>; <name><surname>Dufour</surname><given-names>J. F.</given-names></name>
<source>Biochim. Biophys. Acta</source>
<year>2011</year>, <volume>1807</volume>, <fpage>626</fpage>â<lpage>632</lpage>.<pub-id pub-id-type="pmid">21316334</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata></record></GetRecord></OAI-PMH>